Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females.

Antico-Arciuch VG, Dima M, Liao XH, Refetoff S, Di Cristofano A.

Oncogene. 2010 Oct 21;29(42):5678-86. doi: 10.1038/onc.2010.308. Epub 2010 Aug 2.

2.

Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia.

Paes JE, Ringel MD.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):375-87, viii-ix. doi: 10.1016/j.ecl.2008.01.001. Review.

3.

Estrogen and its role in thyroid cancer.

Derwahl M, Nicula D.

Endocr Relat Cancer. 2014 Oct;21(5):T273-83. doi: 10.1530/ERC-14-0053. Epub 2014 Jul 22. Review.

4.

Treatment directed to signalling molecules in patients with advanced differentiated thyroid cancer.

Sáez JM.

Anticancer Agents Med Chem. 2013 Mar;13(3):483-95. Review.

PMID:
22583421
5.

beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.

Rezk S, Brynes RK, Nelson V, Thein M, Patwardhan N, Fischer A, Khan A.

Endocr Pathol. 2004 Winter;15(4):329-37. Review.

6.
7.

Interlinking of hypoxia and estrogen in thyroid cancer progression.

Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, Suriano R, Carpi A, Tiwari RK.

Curr Med Chem. 2014;21(11):1351-60. Review.

PMID:
24304276
8.

Estrogens and stem cells in thyroid cancer.

Zane M, Catalano V, Scavo E, Bonanno M, Pelizzo MR, Todaro M, Stassi G.

Front Endocrinol (Lausanne). 2014 Jul 25;5:124. doi: 10.3389/fendo.2014.00124. eCollection 2014. Review.

Supplemental Content

Support Center